Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oglemilast in Exercise-Induced Bronchospasm
NCT00322283Phase 2Completed
- Sponsor
- Forest Laboratories
- Start
- May 2006
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oglemilast in exercise-induced bronchoconstriction (EIB), sponsored by Forest Laboratories. Started May 2006; status: completed.
02
Drugs
oglemilast
03
Conditions
exercise-induced bronchoconstriction (EIB)
Beyond the preview
Go deeper on NCT00322283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00322283.